-
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378:607–620
-
Klein AP (2021) Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol 18:493–502
-
Ruze R, Song J, Yin X, Chen Y, Xu R, Wang C, Zhao Y (2023) Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. Signal Transduct Target Ther 8:139
-
Itabe H (2009) Oxidative modification of LDL: its pathological role in atherosclerosis. Clin Rev Allergy Immunol 37:4–11
-
Yokode M (2001) [Oxidized LDL and vascular endothelial dysfunction]. Nihon Rinsho 59 Suppl 2:596–601
-
Jung YY, Ko J-H, Um J-Y, Chinnathambi A, Alharbi SA, Sethi G, Ahn KS (2021) LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. J Cell Physiol 236:5253–5264
-
Revilla G, Cedó L, Tondo M, et al (2021) LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies. Semin Cancer Biol 73:134–157
-
Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer - PubMed. https://pubmed.ncbi.nlm.nih.gov/32066631/. Accessed 14 Jun 2023
-
Carreras-Torres R, Johansson M, Gaborieau V, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Brennan P (2017) The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. J Natl Cancer Inst 109:djx012
-
Lin Y, Tamakoshi A, Hayakawa T, Naruse S, Kitagawa M, Ohno Y (2005) Nutritional factors and risk of pancreatic cancer: a population-based case-control study based on direct interview in Japan. J Gastroenterol 40:297–301
-
Association between cholesterol intake and pancreatic cancer risk: evidence from a meta-analysis - PubMed. https://pubmed.ncbi.nlm.nih.gov/25649888/. Accessed 14 Jun 2023
-
Deng C-F, Zhu N, Zhao T-J, Li H-F, Gu J, Liao D-F, Qin L (2022) Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential. Front Oncol 12:803473
-
Hemani G, Zheng J, Elsworth B, et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408
-
Yavorska OO, Burgess S (2017) MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 46:1734–1739
-
Berrington de Gonzalez A, Yun JE, Lee S-Y, Klein AP, Jee SH (2008) Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev 17:359–364
-
Maisonneuve P, Lowenfels AB (2010) Epidemiology of pancreatic cancer: an update. Dig Dis 28:645–656
-
Aune D, Greenwood DC, Chan DSM, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ, Norat T (2012) Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 23:843–852
-
Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2002) A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 13:417–426
-
Johansen D, Stocks T, Jonsson H, et al (2010) Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev 19:2307–2317
-
Ansary-Moghaddam A, Huxley R, Barzi F, Lawes C, Ohkubo T, Fang X, Jee SH, Woodward M, Asia Pacific Cohort Studies Collaboration (2006) The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 15:2435–2440
-
Batty GD, Kivimaki M, Morrison D, Huxley R, Smith GD, Clarke R, Marmot MG, Shipley MJ (2009) Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study. Cancer Epidemiol Biomarkers Prev 18:673–675
-
Strohmaier S, Edlinger M, Manjer J, et al (2013) Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One 8:e54242
-
Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes D, Larson DB, Licitra LM (1988) Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 48:452–458
-
Wang J, Wang W-J, Zhai L, Zhang D-F (2015) Association of cholesterol with risk of pancreatic cancer: a meta-analysis. World J Gastroenterol 21:3711–3719
-
Chen X, Zhou T, Chen M (2015) Meta analysis of the association of cholesterol with pancreatic carcinoma risk. J BUON 20:109–113
-
van Leeuwen EM, Karssen LC, Deelen J, et al (2015) Genome of The Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels. Nat Commun 6:6065
-
He B, Kang S, Chen Z, Liu X, Wang J, Li X, Liu X, Zheng L, Luo M, Wang Y (2021) Hypercholesterolemia risk associated Abca6 does not regulate lipoprotein metabolism in mice or hamster. Biochim Biophys Acta Mol Cell Biol Lipids 1866:159006
-
Vasseur S, Guillaumond F (2016) LDL Receptor: An open route to feed pancreatic tumor cells. Mol Cell Oncol 3:e1033586
-
Jung YY, Ko J-H, Um J-Y, Chinnathambi A, Alharbi SA, Sethi G, Ahn KS (2021) LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. J Cell Physiol 236:5253–5264